share_log

力生制药:2024年第三次独立董事专门会议审查意见

Lisheng Pharmaceuticals: Review Opinions at the 3rd Special Meeting of Independent Directors in 2024

SZSI ·  Apr 25

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.